GLOBAL MYOMECTOMY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Global Myomectomy Market Size and Trends

Global myomectomy market size is expected to reach US$ 1,600.9 Mn by 2031, from US$ 791.2 Mn in 2023, exhibiting a compound annual growth rate (CAGR) of 9.2% during the forecast period (2024-2031).

Global Myomectomy Market- Trends

• Increasing popularity of minimally invasive procedures: Increasing popularity of minimally invasive surgeries is greatly influencing the myomectomy market. With advancements in laparoscopic and robotic technologies, surgeons have vastly improved surgical tools that allow for more refined and precise procedures through smaller incisions. This dramatic shift away from traditional "open" or abdominal myomectomies towards techniques like laparoscopic myomectomy has sizable benefits for both patients and providers. For patients, minimally invasive options mean less post-operative pain, fewer surgical complications, shorter hospital stays, and quicker recovery times back to normal activities. Smaller incisions reduce risks of infections, scarring, adhesions, and blood loss as compared to traditional "open" surgeries. This leads to an improved patient experience and satisfaction with the procedure. For providers, the precision and control afforded by instruments like the Da Vinci surgical robot, a robotic surgical system that uses a minimally invasive surgical approach, enable nearly scarless surgery and maximized organ protection during removal of uterine fibroids. This helps produce superior outcomes for patients.
• Usage of advanced instruments and medical devices: The myomectomy market has witnessed significant developments in recent years as advanced surgical instruments and medical devices are becoming more commonly used during uterine fibroid removal procedures. Minimally invasive options such as laparoscopic myomectomy allow surgeons to access the uterus through small incisions rather than requiring large abdominal incisions. This has led to advantages for patients such as less blood loss, less pain, shorter hospital stays, and quicker recovery times as compared to open abdominal myomectomy surgeries. Increased accessibility and precision provided by laparoscopic devices has driven their rise in popularity among both doctors and women seeking fibroid treatments. Advancements in laparoscopic techniques and device technologies enable surgeons to remove even very large fibroids by using minimally invasive approaches. Newer bipolar and ultrasonic instruments provide more controlled cutting and coagulation of fibroid tissues compared to older tools. Robotic platforms also give surgeons improved visualization and dexterity when operating through small incisions. The U.S. FDA approval and clinical use of the da Vinci Surgical System and later models for hysterectomies and myomectomies has increased the number of robotic procedures performed in both outpatient hospital settings and freestanding ambulatory surgery centers.